BY MARKETWIRE
-
ALK launches adrenaline nasal spray in Germany
ALK obtained the worldwide civil liberties to the nasal spray from ARS Pharmaceuticals in November 2024.
-
Bavarian Nordic vaccine being tested in infants and pregnant women
Both research studies with the vaccination versus mpox are being performed in the Autonomous Republic of Congo, the center of the recurring mpox episode.
-
Hims & Hers stands firm: Will keep selling cheap weight loss products
Novo Nordisk ended its collaboration with Hims on Monday, pointing out deceitful advertising and marketing about duplicate variations of the preferred weight-loss medication, Wegov…
-
Ambu competitor plunges as US FDA issues warnings about import ban on certain devices
The cautioning refer to Japanese Olympus’ endoscopes utilized for endoscopic exams of the ureters and kidneys, to name a few tools.
-
Novo Nordisk presents detailed data on weight loss candidate cagrisema
Individuals that stuck to the therapy standards attained higher fat burning, according to the Danish pharmaceutical titan.
-
Him & Hers boss hits back after Novo’s decision to end partnership
Hims chief executive officer Andrew Dudum charges Novo Nordisk of pushing the business to place people on Wegovy, no matter whether it was medically best for people.
-
GN gains market share among US veterans in May
At the same time, rival Demant is shedding ground.
-
Trump’s administration’s price policy puts pressure on EU pharma industry
According to professionals, Donald Trump’s “most popular country” plan can cause greater expenses for European health care systems.
-
Novo Nordisk presents detailed data on weight loss candidate cagrisema
Patients who adhered to the treatment guidelines achieved greater weight loss, according to the Danish pharmaceutical giant.
-
Novo Nordisk presents data on higher dose of Wegovy
The business has actually examined three-way dosages of semaglutide.
